期刊文献+
共找到157篇文章
< 1 2 8 >
每页显示 20 50 100
Clinical Study of Endovascular Treatment of Severe Middle Cerebral Artery Stenosis or Occlusion and Vascular Cognitive Impairment
1
作者 Shaojie Yuan Tong Zhang +2 位作者 Xiaohui Zhao Liying Yuan Dan Wang 《Journal of Advances in Medicine Science》 2021年第2期46-50,共5页
It is very important to study the factors affecting the incidence,progress and prognosis of patients with vascular dementia.50 cases of severe middle cerebral artery stenosis or occlusion underwent endovascular treatm... It is very important to study the factors affecting the incidence,progress and prognosis of patients with vascular dementia.50 cases of severe middle cerebral artery stenosis or occlusion underwent endovascular treatment(25 cases of mild cognitive dysfunction,25 cases of moderate cognitive dysfunction)were divided into two groups,where a medical drug treatment group and a control group established with 25 cases in each group.The cognitive function of each group of patients was evaluated before operation,7 days after operation,30 days after operation,and 180 days after operation.CTP was used to compare the hemodynamic changes in patients before and after operation.The severe stenosis or occlusion of the middle cerebral artery in patients can be improved,and the intracranial blood supply of patients with poorly compensated medial cranial circulation and hypoperfusion can be restored to a certain extent.Meanwhile,improvement of cognitive function was definitive in some patients with cognitive dysfunction.To guide the formulation of treatment plans for patients with severe middle cerebral artery stenosis or occlusion. 展开更多
关键词 Acute middle cerebral artery occlusion vascular cognitive impairment Montreal cognitive assessment
下载PDF
Overexpression of vascular endothelial growth factor enhances the neuroprotective effects of bone marrow mesenchymal stem cell transplantation in ischemic stroke 被引量:2
2
作者 Cui Liu Zhi-Xiang Yang +6 位作者 Si-Qi Zhou Ding Ding Yu-Ting Hu Hong-Ning Yang Dong Han Shu-Qun Hu Xue-Mei Zong 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第6期1286-1292,共7页
Although bone marrow mesenchymal stem cells(BMSCs)might have therapeutic potency in ischemic stroke,the benefits are limited.The current study investigated the effects of BMSCs engineered to overexpress vascular endot... Although bone marrow mesenchymal stem cells(BMSCs)might have therapeutic potency in ischemic stroke,the benefits are limited.The current study investigated the effects of BMSCs engineered to overexpress vascular endothelial growth factor(VEGF)on behavioral defects in a rat model of transient cerebral ischemia,which was induced by middle cerebral artery occlusion.VEGF-BMSCs or control grafts were injected into the left striatum of the infarcted hemisphere 24 hours after stroke.We found that compared with the stroke-only group and the vehicle-and BMSCs-control groups,the VEGF-BMSCs treated animals displayed the largest benefits,as evidenced by attenuated behavioral defects and smaller infarct volume 7 days after stroke.Additionally,VEGF-BMSCs greatly inhibited destruction of the blood-brain barrier,increased the regeneration of blood vessels in the region of ischemic penumbra,and reducedneuronal degeneration surrounding the infarct core.Further mechanistic studies showed that among all transplant groups,VEGF-BMSCs transplantation induced the highest level of brain-derived neurotrophic factor.These results suggest that BMSCs transplantation with vascular endothelial growth factor has the potential to treat ischemic stroke with better results than are currently available. 展开更多
关键词 bone marrow mesenchymal stem cell brain-derived neurotrophic factor CD31 microtubule associated protein 2 middle cerebral artery occlusion stroke transplantation vascular endothelial growth factor
下载PDF
Assessment of cerebrovascular reserve impairment using the breath-holding index in patients with leukoaraiosis 被引量:4
3
作者 Ying Bian Jin-Chun Wang +6 位作者 Feng Sun Zi-Yi Sun Yu-Jiao Lin Yang Liu Bin Zhao Li Liu Xiao-Guang Luo 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第8期1412-1418,共7页
Many studies have demonstrated that leukoaraiosis is associated with impaired cerebrovascular reserve function. However, the definitive hemodynamic changes that occur in leukoaraiosis are not clear, and there are many... Many studies have demonstrated that leukoaraiosis is associated with impaired cerebrovascular reserve function. However, the definitive hemodynamic changes that occur in leukoaraiosis are not clear, and there are many controversies. This study aimed to investigate hemodynamic changes in symptomatic leukoaraiosis using transcranial Doppler ultrasonography and the breath-holding test in a Chinese Han population, from northern China. A total of 203 patients who were diagnosed with ischemic stroke or clinical chronic progressive ischemic symptoms were enrolled in this study, including 97 males and 106 females, with an age range of 43-93 years. The severity of leukoaraiosis was evaluated according to the Fazekas grading scale, and patients were divided into four groups accordingly. Grade 0 was no leukoaraiosis, and grades I, II, and III were mild, moderate, and severe leukoaraiosis, respectively, with 44, 79, 44, and 36 cases in each group. Transcranial Doppler ultrasonography and the breath-holding test were performed. The mean blood flow velocity of the bilateral middle cerebral artery was measured and the breath-holding index was calculated. The breath holding index was correlated with leukoaraiosis severity and cognitive impairment. Patients with a low breath holding index presented poor performance in the Montreal Cognitive Assessment (MoCA) and executive function tests. That is, the lower the breath holding index, the lower the scores for the MoCA and the higher for the trail-making test Parts A and B. These results indicate that the breath-holding index is a useful parameter for the evaluation of cerebrovascular reserve impairment in patients with leukoaraiosis. In addition, the breath-holding index can reflect cognitive dysfunction, providing a new insight into the pathophysiology of leukoaraiosis. This study was approved by the Ethics Committee of the Fifth Peoples Hospital of Shenyang, China (approval No. 20160301) and registered in the Chinese Clinical Trial Registry (registration number: ChiCTR1800014421). 展开更多
关键词 nerve REGENERATION cerebral small vascular disease white matter HYPERINTENSITIES cerebral hemodynamics cerebral hypoperfusion middle cerebral artery blood flow velocity breath-holding test breath-holding index cognitive function neural REGENERATION
下载PDF
Rhizoma Chuanxiong regulates vascular endothelial growth factor production in hypoxic human umbilical vein endothelial cells in vitro and in peri-infarct rat brain tissue
4
作者 Muke Zhou Mi Yang Ning Chen Yucai Wang Jian Guo Xue Yang Zhijian Zhang Dong Zhou Li He 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第5期350-357,共8页
BACKGROUND: Vascular endothelial growth factor (VEGF) acts as "molecular bridge" following ischemic stroke to improve and restore blood supply and reduce infarction volume. Clinical studies have demonstrated the ... BACKGROUND: Vascular endothelial growth factor (VEGF) acts as "molecular bridge" following ischemic stroke to improve and restore blood supply and reduce infarction volume. Clinical studies have demonstrated the efficacy of Rhizoma Chuanxiong (Chuanxiong) in the treatment of ischemic cerebrovascular diseases. However, whether it promotes endogenous VEGF expression in ischemic stroke remains unknown. OBJECTIVE: To investigate the influence of Rhizoma Chuanxiong on VEGF production in vitro cultured human umbilical vein endothelial cells and on VEGF expression in ischemic cerebral tissues to explore its role in angiogenesis. DESIGN, TIME AND SETTING: In vitro basic comparison of traditional Chinese drug-containing serum pharmacology; in vivo randomized, controlled, animal experiment. This study was performed at the Medical Laboratory of West China Hospital, Sichuan University between December 2002 and April 2004. MATERIALS: Two Chinese rabbits were selected. One was intragastrically perfused with 5.8 g/kg Rhizoma Chuanxiong extract twice per day for three consecutive days to prepare Rhizoma Chuanxiong extract-containing serum. The remaining rabbit was intragastrically perfused with the same volume of normal saline twice per day for three consecutive days. Rhizoma Chuanxiong extract was provided by Beijing Traditional Chinese Medicine Research Institute, predominantly composed of ligustrazine, ligustilide, and ferulic acid. ChemiKineTM human VEGF Kit was purchased from Chemicon, USA; mouse anti-VEGF monoclonal antibody and biotin-goat anti-mouse IgG were purchased from Santa Cruz Biotechnology. Inc., USA. METHODS: (1) In vitro experiment: in vitro cultured human umbilical vein endothelial cells were separately incubated in rabbit serum with 10% Rhizoma Chuanxiong extract, normal medium without rabbit serum, and rabbit serum without Rhizoma Chuanxiong extract (blank control). In addition, cells from the three groups were incubated under normoxia (5% CO2, 95% air) and hypoxia (1% 02, 5% CO2, 94% N2), respectively, for 24 hours. (2) In vivo experiment: a total of 4/44 Sprague Dawley rats were selected for the sham-operated group (no occlusion), and the remaining rats were used to establish a cerebral ischemiaJreperfusion model by suture occlusion. 32 animals with ischemia/reperfusion injury were randomly divided into treatment and model groups, with 16 rats in each group. Both groups were intraperitoneally infused with 0.58 g/kg Rhizoma Chuanxiong extract and normal saline two hours following reperfusion. The sham-operated group was administrated normal saline. Animals were treated with saline or Chuanxiong extracts (0.58 g/kg) twice per day for three consecutive days. MAIN OUTCOME MEASURES: In vitro experiment: VEGF concentration was detected in each group by enzyme-linked immunosorbent assay. In vivo experiment: behavioral alterations of rats were evaluated by neurological function scale; infarct volume was assessed by hematoxylin-eosin staining; VEGF protein expression in the infarct regions was determined by immunohistochemistry. RESULTS: (1) VEGF levels were similar between the three groups under normexic condition (P 〉 0.05); while hypoxia induced VEGF production (P 〈 0.01 ). VEGF levels in the drug-containing serum group were particularly higher compared with the other groups (P 〈 0.01). (2) Compared with normal saline treatment, Rhizoma Chuanxiong extract significantly improved the neurological scale and reduced cerebral infarct volumes (P〈 0.05). The percent of VEGF-positive cells was significantly greater than the model group (P 〈 0.05). The sham-operated group exhibited normal neurological function, with no infarct focus. CONCLUSION: Rhizoma Chuanxiong extract-containing rabbit serum effectively promoted cultured VEGF production under hypoxia. Rhizoma Chuanxiong extract upregulated VEGF expression in the infarct region, improved neurological function, and reduced infarct size. 展开更多
关键词 Rhizoma Chuanxiong extract vascular endothelial growth factor human umbi endothelial cell middle cerebral artery occlusion angiogenesis neuroprotection d
下载PDF
高分辨磁共振扫描对急性脑梗死患者大脑中动脉血管壁斑块特征分析的应用
5
作者 王秀萍 王平翻 +2 位作者 李豪鹏 焦美艳 王丙聚 《中国CT和MRI杂志》 2024年第3期32-34,共3页
目的分析高分辨磁共振扫描对急性脑梗死患者大脑中动脉血管壁及、斑块特征分析的应用。方法选择2022年1月至2023年1月于我院收治的急性脑梗死患者58例为急性脑梗死组,同期选择短暂性脑缺血患者46例为短暂性脑缺血组,两组患者均行高分辨... 目的分析高分辨磁共振扫描对急性脑梗死患者大脑中动脉血管壁及、斑块特征分析的应用。方法选择2022年1月至2023年1月于我院收治的急性脑梗死患者58例为急性脑梗死组,同期选择短暂性脑缺血患者46例为短暂性脑缺血组,两组患者均行高分辨磁共振检查,比较两组患者大脑中动脉血管壁斑块特征、性质及相关参数,采用受试者工作特征(RDC)曲线评估高分辨磁共振参数诊断急性脑梗死的价值。结果急性脑梗死组患者斑块位置(腹侧壁、上侧壁)、狭窄重构方式(负性)、斑块表面形态(不平整)比例明显高于短暂性脑缺血组,差异具有统计学意义(P<0.05)。急性脑梗死组患者血管最狭窄处管腔面积(LAmln)水平明显低于短暂性脑缺血组,管壁面积(WAmln)、斑块负荷、狭窄率、斑块面积水平明显高于短暂性脑缺血组,差异具有统计学意义(P<0.05)。急性脑梗死组、短暂性脑缺血组患者斑块类型差异无统计学意义(P>0.05)。ROC曲线分析结果显示,LAmln、WAmln、斑块负荷、狭窄率、斑块面积诊断急性脑梗死的曲线下面积(AUC)分别为0.737、0.828、0.779、0.821、0.936(P均<0.05)。结论急性脑梗死患者高分辨磁共振扫描斑块多出现在腹侧壁、上侧壁部位,狭窄呈负性重构、斑块表面形态不平整,LAmlm、WAmlm、斑块负荷、狭窄率、斑块面积呈明显异常表达,在诊断急性脑梗死方面具有一定价值。 展开更多
关键词 高分辨磁共振扫描 急性脑梗死 大脑中动脉 血管壁 斑块特征 应用
下载PDF
Neuroform EZ支架置入对症状性大脑中动脉重度狭窄患者脑血流灌注、血管内皮功能、认知功能及神经功能缺损的干预效果 被引量:5
6
作者 张继伟 李亮 +5 位作者 齐宝柱 孙文浩 于淼 李东 田宇 王广 《国际神经病学神经外科学杂志》 2021年第5期466-470,共5页
目的探讨NeuroformEZ支架置入辅助治疗症状性大脑中动脉重度狭窄的临床效果。方法回顾性分析2016年10月至2019年10月该院症状性大脑中动脉重度狭窄患者85例临床资料,按治疗方案不同分为观察组(43例)、对照组(42例)。对照组予以单纯药物... 目的探讨NeuroformEZ支架置入辅助治疗症状性大脑中动脉重度狭窄的临床效果。方法回顾性分析2016年10月至2019年10月该院症状性大脑中动脉重度狭窄患者85例临床资料,按治疗方案不同分为观察组(43例)、对照组(42例)。对照组予以单纯药物治疗,观察组在药物治疗基础上联合NeuroformEZ支架置入术。比较两组术后1年疗效、不良事件发生情况;比较两组及术前、术后6个月、术后1年认知功能评分(MMSE)、神经功能缺损程度评分(NIHSS)、脑血流灌注指标[脑血流量(CBF)、脑血容量(CBV)]、血管内皮功能指标[一氧化氮(NO)、内皮素(ET)]。结果观察组术后1年总有效率为95.35%,高于对照组78.57%,差异有统计学意义(P<0.05)。两组术后6个月、1年MMSE评分及CBF、CBV、NO水平较术前提高,且观察组高于对照组,差异有统计学意义(P<0.05)。NIHSS评分及ET水平较术前降低,且观察组低于对照组,差异有统计学意义(P<0.05)。观察组不良事件发生率为13.95%,低于对照组33.33%,差异有统计学意义(P<0.05)。结论NeuroformEZ支架置入辅助治疗症状性大脑中动脉重度狭窄可促进认知与神经功能改善,且在改善脑血流灌注、血管内皮功能、减少不良事件方面具有积极作用。 展开更多
关键词 症状性大脑中动脉狭窄 Neuroform EZ支架置入术 脑血流灌注 血管内皮功能 认知功能 神经功能缺损
下载PDF
A more consistent intraluminal rhesus monkey model of ischemic stroke 被引量:6
7
作者 Bo Zhao Guowei Shang +11 位作者 Jian Chen Xiaokun Geng Xin Ye Guoxun Xu Ju Wang Jiasheng Zheng Hongjun Li Fauzia Akbary Shengli Li Jing Lu Feng Ling Xunming Ji 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第23期2087-2094,共8页
Endovascular surgery is advantageous in experimentally induced ischemic stroke because it causes fewer cranial traumatic lesions than invasive surgery and can closely mimic the pathophysiology in stroke patients. Howe... Endovascular surgery is advantageous in experimentally induced ischemic stroke because it causes fewer cranial traumatic lesions than invasive surgery and can closely mimic the pathophysiology in stroke patients. However, the outcomes are highly variable, which limits the accuracy of evaluations of ischemic stroke studies. In this study, eight healthy adult rhesus monkeys were randomized into two groups with four monkeys in each group: middle cerebral artery occlusion at origin segment (M1) and middle cerebral artery occlusion at M2 segment. The blood flow in the middle cerebral artery was blocked completely for 2 hours using the endovascular microcoil placement technique (1 mm × 10 cm) (undetachable), to establish a model of cerebral ischemia. The microcoil was withdrawn and the middle cerebral artery blood flow was restored. A reversible middle cerebral artery occlusion model was identified by hematoxylin-eosin staining, digital subtraction angiography, magnetic resonance angiography, magnetic resonance imaging, and neurological evaluation. The results showed that the middle cerebral artery occlusion model was successfully established in eight adult healthy rhesus monkeys, and ischemic lesions were apparent in the brain tissue of rhesus monkeys at 24 hours after occlusion. The rhesus monkeys had symptoms of neurological deficits. Compared with the M1 occlusion group, the M2 occlusion group had lower infarction volume and higher neurological scores. These experimental findings indicate that reversible middle cerebral artery occlusion can be produced with the endovascular microcoil technique in rhesus monkeys. The M2 occluded model had less infarction and less neurological impairment, which offers the potential for application in the field of brain injury research. 展开更多
关键词 nerve regeneration brain injury rhesus monkeys model middle cerebral artery MICROCOIL INFARCTION stroke interventional therapy digital subtraction angiography magnetic resonance image NEUROIMAGING NEUROREGENERATION
下载PDF
Exacerbated VEGF up-regulation accompanies diabetes-aggravated hemorrhage in mice after experimental cerebral ischemia and delayed reperfusion 被引量:1
8
作者 Angela Ka Wai Lai Tsz Chung Ng +4 位作者 Victor Ka Lok Hung Ka Cheung Tam Chi Wai Cheung Sookja Kim Chung Amy Cheuk Yin Lo 《Neural Regeneration Research》 SCIE CAS CSCD 2022年第7期1566-1575,共10页
Reperfusion therapy is the preferred treatment for ischemic stroke,but is hindered by its short treatment window,especially in patients with diabetes whose reperfusion after prolonged ischemia is often accompanied by ... Reperfusion therapy is the preferred treatment for ischemic stroke,but is hindered by its short treatment window,especially in patients with diabetes whose reperfusion after prolonged ischemia is often accompanied by exacerbated hemorrhage.The mechanisms underlying exacerbated hemorrhage are not fully understood.This study aimed to identify this mechanism by inducing prolonged 2-hour transient intraluminal middle cerebral artery occlusion in diabetic Ins2Akita/+mice to mimic patients with diabetes undergoing delayed mechanical thrombectomy.The results showed that at as early as 2 hours after reperfusion,Ins2Akita/+mice exhibited rapid development of neurological deficits,increased infarct and hemorrhagic transformation,together with exacerbated down-regulation of tight-junction protein ZO-1 and upregulation of blood-brain barrier-disrupting matrix metallopeptidase 2 and matrix metallopeptidase 9 when compared with normoglycemic Ins2+/+mice.This indicated that diabetes led to the rapid compromise of vessel integrity immediately after reperfusion,and consequently earlier death and further aggravation of hemorrhagic transformation 22 hours after reperfusion.This observation was associated with earlier and stronger up-regulation of pro-angiogenic vascular endothelial growth factor(VEGF)and its downstream phospho-Erk1/2 at 2 hours after reperfusion,which was suggestive of premature angiogenesis induced by early VEGF up-regulation,resulting in rapid vessel disintegration in diabetic stroke.Endoplasmic reticulum stress-related pro-apoptotic C/EBP homologous protein was overexpressed in challenged Ins2Akita/+mice,which suggests that the exacerbated VEGF up-regulation may be caused by overwhelming endoplasmic reticulum stress under diabetic conditions.In conclusion,the results mimicked complications in patients with diabetes undergoing delayed mechanical thrombectomy,and diabetes-induced accelerated VEGF up-regulation is likely to underlie exacerbated hemorrhagic transformation.Thus,suppression of the VEGF pathway could be a potential approach to allow reperfusion therapy in patients with diabetic stroke beyond the current treatment window.Experiments were approved by the Committee on the Use of Live Animals in Teaching and Research of the University of Hong Kong[CULATR 3834-15(approval date January 5,2016);3977-16(approval date April 13,2016);and 4666-18(approval date March 29,2018)]. 展开更多
关键词 blood-brain barrier brain injury diabetes mellitus hemorrhagic transformation INFARCT ischemia/reperfusion injury middle cerebral artery occlusion mouse model stroke vascular endothelial growth factor
下载PDF
Sofia远端通路导管在急性前循环大血管闭塞取栓治疗中的应用 被引量:1
9
作者 朱敏真 陈长兵 +1 位作者 张文胜 何锦照 《国际医药卫生导报》 2021年第14期2106-2109,共4页
目的探究Sofia远端通路导管在急性前循环大血管闭塞取栓治疗中的应用。方法选择2019年6月至2020年6月在本院行介入治疗的急性缺血性脑卒中患者20例为研究对象,依据治疗方式将其分为单纯抽吸组15例与联合治疗组5例。单纯抽吸组男9例,女6... 目的探究Sofia远端通路导管在急性前循环大血管闭塞取栓治疗中的应用。方法选择2019年6月至2020年6月在本院行介入治疗的急性缺血性脑卒中患者20例为研究对象,依据治疗方式将其分为单纯抽吸组15例与联合治疗组5例。单纯抽吸组男9例,女6例,年龄(67.3±12.8)岁;联合治疗组男3例,女2例,年龄(68.5±14.2)岁。单纯抽吸组在穿刺后仅给予单纯抽吸血栓治疗,联合治疗组在上述治疗反复抽吸不通的情况下联合支架取栓术。评估两组患者股动脉穿刺成功到血管再通的时间、发病到血管再通的时间、血管开通程度、美国国立卫生研究院卒中量表(NIHSS)评分及相关并发症的差异。结果单纯抽吸组和联合治疗组从股动脉穿刺成功到血管再通的时间分别为23(15,37)min和33(29,51)min,单纯抽吸组要比联合治疗组短,差异有统计学意义(Z=-2.783,P=0.013)。术后24 h两组NIHSS评分为10(5,13)分比8(3,9)分(Z=-0.893,P=0.138),术后7 d两组NIHSS评分为7(2,12)分比5(3,7)分(Z=-1.738,P=0.127),较治疗前均有好转,但组间差异均无统计学意义(均P>0.05)。联合治疗组颅内出血和血栓逃逸发生率分别为20.00%(1/5)、0.00%(0/5),单纯抽吸组为20.00%(3/15)、13.33%(2/15),差异均无统计学意义(均P>0.05)。结论相对单纯支架取栓或抽吸联合支架取栓来说,采用Sofia远端通路导管在急性前循环大血管闭塞取栓治疗中具有相似治疗效果和安全性,且该方式具有操作简单、耗时少等特点。 展开更多
关键词 Sofia远端通路导管 大脑中动脉 血栓抽吸术 机械取栓 血管内治疗
下载PDF
急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的影响因素 被引量:1
10
作者 陈鹏 马己才 陈俊斌 《中国当代医药》 CAS 2023年第7期80-83,共4页
目的探讨急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的影响因素。方法选取2020年1月至2021年12月于粤北人民医院神经内科接受血管内介入治疗的62例急性大脑中动脉闭塞性脑梗死患者作为研究对象,于术后随访90 d,依据改良Rankin量表(m... 目的探讨急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的影响因素。方法选取2020年1月至2021年12月于粤北人民医院神经内科接受血管内介入治疗的62例急性大脑中动脉闭塞性脑梗死患者作为研究对象,于术后随访90 d,依据改良Rankin量表(mRS)评分将其分为预后良好组(n=47,mRS评分≤2分)与预后不良组(n=15,mRS评分≥3分);收集两组患者的年龄、性别等一般资料,运用多因素logistic回归分析模型分析急性大脑中动脉闭塞性脑梗死患者经血管内介入治疗后预后的影响因素。结果单因素分析结果显示,性别、体重指数(BMI)、复合再通方法与急性大脑中动脉闭塞性脑梗死患者血管内介入治疗预后无关,差异无统计学意义(P>0.05);年龄、有无脑水肿、术前美国国立卫生研究院卒中量表(NIHSS)评分、糖尿病史与患者血管内介入治疗预后有关,差异有统计学意义(P<0.05)。logistic回归模型进行多因素分析结果显示,年龄≥60岁(β=2.773,OR=16.000,95%CI=3.713~68.955)、有脑水肿(β=2.942,OR=18.958,95%CI=3.727~96.441)、术前NIHSS评分≥15分(β=2.320,OR=10.175,95%CI=2.662~38.887)、有糖尿病史(β=2.320,OR=10.175,95%CI=2.662~38.887)是急性大脑中动脉闭塞性脑梗死患者血管内介入治疗后预后的独立危险因素(P<0.05)。结论急性大脑中动脉闭塞性脑梗死患者经血管内介入治疗后预后不良的因素具有多样性,如年龄≥60岁、有脑水肿、术前NIHSS评分≥15分、有糖尿病史,临床需对此种情况予以高度重视。 展开更多
关键词 急性大脑中动脉闭塞性脑梗死 血管内介入治疗 预后 影响因素
下载PDF
芹菜素通过VEGF通路对大脑中动脉阻塞后大鼠脑缺血半暗带血管神经再生的影响
11
作者 刘婵 胡权 +2 位作者 谢庆凤 朱安奇 陈翔 《温州医科大学学报》 CAS 2023年第3期182-188,共7页
目的:探讨芹菜素促大脑中动脉阻塞(MCAO)后大鼠脑缺血半暗带血管生成和神经再生的作用,以及是否与血管内皮生长因子(VEGF)信号通路有关。方法:将144只SD大鼠分为假手术组(S7、S14)、模型组(M7、M14)、芹菜素模型组(AM7、AM14)和芹菜素+V... 目的:探讨芹菜素促大脑中动脉阻塞(MCAO)后大鼠脑缺血半暗带血管生成和神经再生的作用,以及是否与血管内皮生长因子(VEGF)信号通路有关。方法:将144只SD大鼠分为假手术组(S7、S14)、模型组(M7、M14)、芹菜素模型组(AM7、AM14)和芹菜素+VEGF受体(VEGF-R)抑制剂模型组(AIM7、AIM14)。构建MCAO模型后,采用改良神经行为学评分(mNSS)和TTC染色评估神经功能和脑梗死体积,采用Western blot、免疫组化和免疫荧光评估脑缺血半暗带中VEGF表达水平以及血管生成和新生神经元的变化。结果:与S组比较,M组、AM组和AIM组均出现不同程度的神经行为学异常和白色梗死灶,AM组较同期M组的mNSS评分降低、脑梗死体积减小(P<0.05);缺血半暗带AM组与同期M组比较VEGF表达增加(P<0.01),AM7组较M7组的脑微血管密度增高(P<0.05);AM7组BrdU/Nestin和AM14组BrdU/NeuN的双标阳性细胞数目均较同期M组明显升高(P<0.01);但VEGF-R抑制剂均可下调芹菜素的上述作用。结论:芹菜素可通过上调VEGF信号通路促进脑缺血半暗带血管生成和神经再生,改善局灶性脑缺血再灌注所致的神经功能缺损。 展开更多
关键词 芹菜素 大脑中动脉阻塞 血管内皮生长因子 血管生成 神经再生
下载PDF
单侧MCA慢性闭塞患者FVH变化规律及其对脑梗死的预测作用 被引量:1
12
作者 师强 杨增烨 +1 位作者 郑莹莹 师宁 《西部医学》 2023年第10期1537-1540,1544,共5页
目的探讨单侧大脑中动脉(MCA)慢性闭塞患者MRI液体衰减反转恢复序列高信号血管征(FVH)的变化规律及其对脑梗死的预测作用。方法选取我院2019年1月-2021年1月收治的121例单侧MCA慢性闭塞患者,行回顾性分析,按有无FVH分为FVH组(36例)和非... 目的探讨单侧大脑中动脉(MCA)慢性闭塞患者MRI液体衰减反转恢复序列高信号血管征(FVH)的变化规律及其对脑梗死的预测作用。方法选取我院2019年1月-2021年1月收治的121例单侧MCA慢性闭塞患者,行回顾性分析,按有无FVH分为FVH组(36例)和非FVH组(85例)。统计分析两组临床资料数据并采用受试者工作特征(ROC)曲线分析FVH对脑梗死的预测作用。结果FVH组脑梗死发生率显著高于非FVH组,差异有统计意义(χ^(2)=4.130,P=0.042),两组性别、年龄、BMI等一般资料相比差异无统计意义(P>0.05)。121例单侧MCA慢性闭塞患者,发生脑梗死80例,占比66.12%。脑梗死者阿尔伯塔卒中项目早期CT评分(ASPECTs)显著高于非脑梗死者,差异有统计意义(t=10.291,P<0.001)。ROC曲线分析显示,FVH的ASPECTs评分预测单侧MCA慢性闭塞患者脑梗死的AUC为0.847(P<0.01)。结论FVH出现提示单侧MCA慢性闭塞患者脑血流灌注发生异常进展,脑梗死发生风险升高,其ASPECTs评分对患者发生脑梗死具有中等预测价值。 展开更多
关键词 脑梗死 慢性闭塞 大脑中动脉 单侧 液体衰减反转恢复序列高信号血管征
下载PDF
HR-MRI分析MCAS患者管壁特征和斑块与卒中风险的关系 被引量:2
13
作者 戴迎桂 张娴娴 +2 位作者 董从松 刘洋 柏荣荣 《中国CT和MRI杂志》 2023年第10期53-55,共3页
目的利用高分辨率磁共振(HR-MRI)分析大脑中动脉狭窄(MCAS)患者管壁特征和斑块与卒中风险的关系。方法选取2020年10月至2022年10月在本院收治的MCAS患者78例,根据其是否发生急性卒中分为急性卒中组(n=36)和非急性卒中组(n=42),均完善HR-... 目的利用高分辨率磁共振(HR-MRI)分析大脑中动脉狭窄(MCAS)患者管壁特征和斑块与卒中风险的关系。方法选取2020年10月至2022年10月在本院收治的MCAS患者78例,根据其是否发生急性卒中分为急性卒中组(n=36)和非急性卒中组(n=42),均完善HR-MRI检查,比较两组患者MCA狭窄处血管壁及斑块特征,利用多因素Logistic回归分析影响M CAS患者的独立危险因素,ROC曲线评价指标预测MCAS患者卒中的价值。结果急性卒中组LA值低于非急性卒中组,NWI、PA值高于非急性卒中组,斑块强化程度高于非急性卒中组,正性重构率高于非急性卒中组(P<0.05);多因素Logistic回归分析显示LA、PA值和斑块强化程度为影响MCAS患者发生急性卒中的独立危险因素(P<0.05)。ROC曲线分析结果示LA、PA值和斑块强化程度均具有预测MCAS患者急性卒中的价值(P<0.05)。结论HRM RI可对M CAS患者管壁特征和斑块特征进行评估,LA、PA值和斑块强化程度是影响MCAS患者发生卒中的独立危险因素,且具有预测价值。 展开更多
关键词 高分辨率磁共振 大脑中动脉狭窄 管壁特征 斑块特征 卒中风险
下载PDF
miR-181b promotes angiogenesis and neurological function recovery after ischemic stroke 被引量:4
14
作者 Li-Xia Xue Lin-Yuan Shu +6 位作者 Hong-Mei Wang Kai-Li Lu Li-Gang Huang Jing-Yan Xiang Zhi Geng Yu-Wu Zhao Hao Chen 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第9期1983-1989,共7页
Promotion of new blood vessel formation is a new strategy for treating ischemic stroke.Non-coding miRNAs have been recently considered potential therapeutic targets for ischemic stroke.miR-181b has been shown to promo... Promotion of new blood vessel formation is a new strategy for treating ischemic stroke.Non-coding miRNAs have been recently considered potential therapeutic targets for ischemic stroke.miR-181b has been shown to promote angiogenesis in hypoxia and traumatic brain injury model,while its effect on ischemic stroke remains elusive.In this study,we found that overexpression of miR-181b in brain microvascular endothelial cells subjected to oxygen-glucose deprivation in vitro restored cell prolife ration and enhanced angiogenesis.In rat models of focal cerebral ischemia,ove rexpression of miR-181b reduced infarction volume,promoted angiogenesis in ischemic penumbra,and improved neurological function.We further investigated the molecular mechanism by which miR-181b participates in angiogenesis after ischemic stroke and found that miR-181b directly bound to the 3’-UTR of phosphatase and tensin homolog(PTEN) mRNA to induce PTEN downregulation,leading to activation of the protein kinase B(Akt) pathway,upregulated expression of vascular endothelial growth facto rs,down-regulated expression of endostatin,and promoted angiogenesis.Taken togethe r,these results indicate that exogenous miR-181b exhibits neuroprotective effects on ischemic stro ke through activating the PTEN/Akt signal pathway and promoting angiogenesis. 展开更多
关键词 Akt ANGIOGENESIS ENDOSTATIN ischemic stroke middle cerebral artery occlusion miR-181b neurological function recovery oxygen-glucose deprivation PTEN vascular endothelial growth factor
下载PDF
远隔缺血预适应通过激活HIF-1α/VEGF通路保护大鼠缺血性脑卒中 被引量:2
15
作者 邹正 付丽丽 +2 位作者 费爽 石佐林 冯思哲 《神经解剖学杂志》 CAS CSCD 2023年第3期341-345,共5页
目的:研究远隔缺血预适应(RIPC)对大鼠脑缺血模型的保护作用及分子机制。方法:30只成年雄性SD大鼠随机分为4组:假手术组(sham)、RIPC组、缺血再灌注组(MCAO/R)组、RIPC+MCAO/R组;术前通过夹闭双侧股动脉给予相应组RIPC处理,利用大脑中... 目的:研究远隔缺血预适应(RIPC)对大鼠脑缺血模型的保护作用及分子机制。方法:30只成年雄性SD大鼠随机分为4组:假手术组(sham)、RIPC组、缺血再灌注组(MCAO/R)组、RIPC+MCAO/R组;术前通过夹闭双侧股动脉给予相应组RIPC处理,利用大脑中动脉栓塞再灌注法(MCAO/R)制备大鼠缺血性脑卒中模型,神经功能评分检测大鼠的神经功能,用2,3,5-三苯四唑氯(TTC)对脑切片进行染色以评估脑梗死的程度。利用real time RT-PCR检测大脑皮质中低氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF) mRNA的表达。结果:与MCAO/R组大鼠相比,RIPC处理组大鼠神经功能缺损症状较轻(P<0.05),脑梗死体积缩小(P<0.01),皮质中HIF-1α和VEGF mRNA的表达表达明显升高(P<0.05)。结论:RIPC处理对减轻缺血性脑卒中大鼠具有保护作用,其分子机制可能与激活HIF-1α/VEGF通路有关。 展开更多
关键词 远隔缺血预适应 大脑中动脉栓塞 缺血性脑卒中 低氧诱导因子-1Α 血管内皮生长因子 大鼠
下载PDF
机械取栓联合血管介入溶栓治疗急性脑梗死患者的效果
16
作者 张洪淞 刘擎 《中国民康医学》 2023年第10期37-40,共4页
目的:观察机械取栓联合血管介入溶栓治疗急性脑梗死患者的效果。方法:选取2020年3月至2022年3月佳木斯市中心医院收治的60例急性脑梗死患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各30例。对照组实施血管介入溶栓治疗,... 目的:观察机械取栓联合血管介入溶栓治疗急性脑梗死患者的效果。方法:选取2020年3月至2022年3月佳木斯市中心医院收治的60例急性脑梗死患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各30例。对照组实施血管介入溶栓治疗,观察组实施机械取栓联合血管介入溶栓治疗,比较两组临床疗效、脑动脉内径及血流速度、即刻mTICI血流分级及不良事件发生率。结果:观察组治疗总有效率为96.67%,高于对照组的73.33%,差异有统计学意义(P<0.05);治疗后,观察组颈总动脉、颈内动脉与椎动脉内径与血流速度均大于对照组,差异有统计学意义(P<0.05);观察组mTICI血流分级优于对照组,差异有统计学意义(P<0.05);两组并发症发生率比较,差异无统计学意义(P>0.05)。结论:机械取栓联合血管介入溶栓治疗急性脑梗死患者,可提高临床疗效,改善患者脑血管血流状态,扩大血流灌注区域,其效果优于单纯血管介入溶栓治疗。 展开更多
关键词 血管介入溶栓 机械取栓 急性脑梗死 脑动脉内径 血流速度
下载PDF
MRI高清血管壁成像在大脑中动脉粥样硬化斑块评估中的应用价值
17
作者 李剑波 徐新超 《影像研究与医学应用》 2023年第17期23-25,29,共4页
目的:探究MRI高清血管壁成像在大脑中动脉粥样硬化斑块评估中的应用价值。方法:回顾性分析2022年6月—2023年6月在华南理工大学附属第六医院就诊的72例大脑中动脉狭窄患者的临床资料,依据MRI和临床表现分成有症状组(40例)和无症状组(32... 目的:探究MRI高清血管壁成像在大脑中动脉粥样硬化斑块评估中的应用价值。方法:回顾性分析2022年6月—2023年6月在华南理工大学附属第六医院就诊的72例大脑中动脉狭窄患者的临床资料,依据MRI和临床表现分成有症状组(40例)和无症状组(32例),收集并比较两组临床和MRI高清血管壁成像资料,采用多因素Logistic回归分析患者出现症状性狭窄的影响因素。结果:两组斑块分布位置比较差异有统计学意义(P<0.05),其中有症状组斑块主要分布于腹侧壁(47.50%),无症状组主要分布于下侧壁(43.75%);两组狭窄率和斑块面积(PA)比较差异无统计学意义(P> 0.05),有症状组重塑指数(RI)、斑块负荷和斑块强化程度大于无症状组(P<0.05);经Logistic回归分析斑块强化程度是大脑中动脉症状性狭窄的影响因素(P<0.05)。结论:MRI高清血管壁成像对大脑中动脉粥样硬化斑块位置、形态和强化等方面的评估具有重要价值,其中症状性狭窄在斑块重塑方式、负荷和强化方面更具显著性,斑块强化程度是其重要影响因素。 展开更多
关键词 大脑中动脉粥样硬化 磁共振高清血管壁成像 斑块负荷 动脉重塑
下载PDF
大脑中动脉远端血管介入术中应用三维DSA技术导航定位的效果分析
18
作者 陈玉双 杨妙芬 +3 位作者 庄少鹉 刘敬山 吴采华 黄文镇 《中外医学研究》 2023年第22期81-85,共5页
目的:探讨分析大脑中动脉远端血管介入术中应用三维数字减影血管造影(DSA)技术导航定位的临床效果。方法:选取福建医科大学附属漳州市医院介入科2020年1月-2022年6月收治的230例大脑中动脉远端血管介入术患者为研究对象,按随机抽签方法... 目的:探讨分析大脑中动脉远端血管介入术中应用三维数字减影血管造影(DSA)技术导航定位的临床效果。方法:选取福建医科大学附属漳州市医院介入科2020年1月-2022年6月收治的230例大脑中动脉远端血管介入术患者为研究对象,按随机抽签方法分为对照组(n=110,传统二维DSA引导)与观察组(n=120,三维DSA技术导航定位)。比较两组手术相关操作时间、检测过程相关剂量、术中引导难度等情况。结果:观察组手术时间、微导管导引时间及X线透视时间均短于对照组,差异有统计学意义(P<0.05)。观察组对比剂用量、空气比释动能(AK)、剂量-面积乘积(DAP)水平及术中引导难度均低于对照组,差异有统计学意义(P<0.05)。结论:大脑中动脉远端血管介入术中应用三维DSA技术导航定位,能够显著缩短手术时间、微导管导引时间及X线透视时间,降低对比剂用量、AK、DAP水平及术中引导难度。 展开更多
关键词 大脑中动脉远端血管介入术 三维DSA技术 导航定位 术中引导难度
下载PDF
支架机械取栓术治疗前循环M2、A2段急性血管闭塞的临床疗效分析
19
作者 李长江 刘天助 +2 位作者 白雪 张文露 邓世宇 《现代医药卫生》 2023年第9期1469-1473,共5页
目的探讨支架机械取栓术治疗前循环大脑中动脉(MCA)M2段、大脑前动脉(ACA)A2段急性血管闭塞的有效性、安全性,分析其危险因素。方法纳入2020年5月至2022年2月在该院神经内科接受治疗的MCA M2段、ACA A2段急性血管闭塞患者共40例。据患... 目的探讨支架机械取栓术治疗前循环大脑中动脉(MCA)M2段、大脑前动脉(ACA)A2段急性血管闭塞的有效性、安全性,分析其危险因素。方法纳入2020年5月至2022年2月在该院神经内科接受治疗的MCA M2段、ACA A2段急性血管闭塞患者共40例。据患者及家属意愿、临床决策分为支架机械取栓组(n=17)和药物治疗组(n=23)。主要评价2组患者治疗后90 d的改良Rankin量表(mRS)评分,以及并发症发生情况、死亡率,分析危险因素。结果支架机械取栓组患者治疗后90 d mRS评分明显低于药物治疗组,差异有统计学意义(P<0.05)。基于倾向性得分加权的logistic回归模型显示,支架机械取栓组出现90 d mRS评分大于2分的风险低于药物治疗组,差异有统计学意义[OR支架机械取栓组=0.344,95%CI(0.121,0.977),P=0.045]。结论支架机械取栓术治疗MCA M2段、ACA A2段急性闭塞,尤其是MCA M2段急性闭塞,安全、有效,可能是良好预后的保护性因素。 展开更多
关键词 急性缺血性脑梗死 大脑中动脉 大脑前动脉 急性血管闭塞 支架机械取栓术
下载PDF
脑白质疏松与急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的关系
20
作者 陈鹏 郭俊辉 谷玉平 《青岛医药卫生》 2023年第4期258-261,共4页
目的探讨脑白质疏松(Leukoaraiosis,LA)与急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的关系。方法选取2021年1月至2021年12月于本院神经内科接受血管内介入治疗的60例急性大脑中动脉闭塞性脑梗死患者,严格依据术前CT平扫影像与van S... 目的探讨脑白质疏松(Leukoaraiosis,LA)与急性大脑中动脉闭塞性脑梗死血管内介入治疗预后的关系。方法选取2021年1月至2021年12月于本院神经内科接受血管内介入治疗的60例急性大脑中动脉闭塞性脑梗死患者,严格依据术前CT平扫影像与van Swieten量表进行LA严重程度分级,其中37例无-轻度LA患者设定为对照组,23例中-重度LA患者设定为观察组,于术后随访90d。对比两组预后,运用多因素Logistic回归分析模型评估LA严重程度与血管内介入治疗术后90d预后的关系。结果观察组术后24h内症状性颅内出血率(43.48%)、术后90d改良Rankin量表(mRS)评分[(2.78±0.63)分]高于对照组[8.11%、(1.69±0.42)分],术后90d预后良好率(60.87%)低于对照组(91.89%),有统计学差异(P<0.05);两组术后90d死亡率相比,无统计学差异(P>0.05);多因素Logistic回归分析显示:LA严重程度是影响急性大脑中动脉闭塞性脑梗死血管内介入治疗后预后不良的危险因素(OR=7.000,95%CI=1.659-29.540,P=0.008)。结论合并LA的急性大脑中动脉闭塞性脑梗死患者,经血管内介入治疗预后不良发生风险较高,且LA程度越重,预后更差,临床需予以重视。 展开更多
关键词 脑白质疏松 急性大脑中动脉闭塞性脑梗死 血管内介入治疗 预后
下载PDF
上一页 1 2 8 下一页 到第
使用帮助 返回顶部